SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-281005
Filing Date
2015-08-06
Accepted
2015-08-06 16:10:13
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d79502d10q.htm 10-Q 358809
2 EX-31.1 d79502dex311.htm EX-31.1 6629
3 EX-31.2 d79502dex312.htm EX-31.2 6886
4 EX-32.1 d79502dex321.htm EX-32.1 3905
5 EX-32.2 d79502dex322.htm EX-32.2 3860
  Complete submission text file 0001193125-15-281005.txt   2432231

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT flxn-20150630.xml EX-101.INS 374354
7 XBRL TAXONOMY EXTENSION SCHEMA flxn-20150630.xsd EX-101.SCH 32946
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE flxn-20150630_cal.xml EX-101.CAL 53089
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE flxn-20150630_def.xml EX-101.DEF 80057
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE flxn-20150630_lab.xml EX-101.LAB 268441
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flxn-20150630_pre.xml EX-101.PRE 186274
Mailing Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803
Business Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803 (781) 305-7777
Flexion Therapeutics Inc (Filer) CIK: 0001419600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36287 | Film No.: 151033208
SIC: 2834 Pharmaceutical Preparations